CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

171 hedge funds and large institutions have $2.04B invested in Crinetics Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 81 increasing their positions, 29 reducing their positions, and 19 closing their positions.

Holders
171
Holders Change
+31
Holders Change %
+22.14%
% of All Funds
2.73%
Holding in Top 10
13
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+116.67%
% of All Funds
0.21%
New
51
Increased
81
Reduced
29
Closed
19
Calls
$31.7M
Puts
$33.7M
Net Calls
-$1.96M
Net Calls Change
-$1.54M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$126M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$76.7M
3
CAM
3
Cormorant Asset Management
Massachusetts
$32.8M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$63.7M
5
Jennison Associates
5
Jennison Associates
New York
$42.6M

Top Sellers

1
O
1
OrbiMed
New York
$86.1M
2
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$37.9M
3
PA
3
Perceptive Advisors
New York
$37.6M
4
FC
4
Finepoint Capital
Massachusetts
$0
5
OM
5
Opaleye Management
Massachusetts
$11M
Name Market Value Shares Shares
Change 		Shares
Change %
DCM
1
Driehaus Capital Management
Illinois
$153M 5,132,287 -165,801 -3%
BlackRock
2
BlackRock
New York
$144M 4,845,717 +245,231 +5%
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$126M 4,225,300 +4,225,300 New
Wellington Management Group
4
Wellington Management Group
Massachusetts
$108M 3,640,235 +38,523 +1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$101M 3,407,035 +674,301 +25%
O
6
OrbiMed
New York
$86.1M 2,896,074 -1,054,722 -27%
State Street
7
State Street
Massachusetts
$84.8M 2,852,720 +614,985 +27%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$76.7M 2,578,199 +1,149,289 +80%
PBA
9
Paradigm Biocapital Advisors
New York
$64.8M 2,178,737 +783,735 +56%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$63.7M 2,140,861 +1,057,947 +98%
T. Rowe Price Investment Management
11
T. Rowe Price Investment Management
Maryland
$48.8M 1,640,692 +676,687 +70%
FLSM
12
Frazier Life Sciences Management
California
$47.3M 1,589,931 +175,108 +12%
FLAM
13
First Light Asset Management
Minnesota
$47.1M 1,583,329 +26,107 +2%
EC
14
EcoR1 Capital
California
$45.5M 1,530,263 +200,000 +15%
Jennison Associates
15
Jennison Associates
New York
$42.6M 1,433,691 +972,194 +211%
BCLSI
16
Bain Capital Life Sciences Investors
Massachusetts
$37.9M 1,275,552 -1,030,006 -45%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$37.8M 1,269,674 +282,184 +29%
PA
18
Perceptive Advisors
New York
$37.6M 1,263,732 -683,205 -35%
SVCM
19
Saturn V Capital Management
Texas
$33.5M 1,126,579 +187,902 +20%
CAM
20
Cormorant Asset Management
Massachusetts
$32.8M 1,101,904 +1,101,904 New
NHAS
21
Novo Holdings A/S
Denmark
$32.7M 1,100,000 – –
EAM
22
Eventide Asset Management
Massachusetts
$30.3M 1,018,782 +584,014 +134%
IC
23
Ikarian Capital
Texas
$23.6M 792,920 +317,920 +67%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$22.2M 744,816 +225,707 +43%
BNP Paribas Asset Management
25
BNP Paribas Asset Management
France
$18.8M 633,364 -7,981 -1%
1
2 3 4 5